Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foss

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Stroke|July 23, 2019
Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic StrokeGustavo Saposnik, Bijoy K Menon, Nima Kashani, et al.
The Journal of Allergy and Clinical Immunology. Global|January 8, 2026
Application of a natural language processing algorithm to early asthma ascertainment for adults in the era of electronic health recordsChung-Il Wi, Thanai Pongdee, Hee Yun Seol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2024
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaFrancine M Foss, Youn H Kim, H Miles Prince, et al.
Blood Advances|February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysisJoseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Blood|December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL ConsortiumMark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
British Journal of Haematology|April 20, 2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project NetworkMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Blood Advances|November 10, 2025
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative AnalysisJoseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Blood Advances|January 13, 2022
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomasMin Jung Koh, Mwanasha H Merrill, Min Ji Koh, et al.
Nature Genetics|July 21, 2015
Genomic landscape of cutaneous T cell lymphomaJaehyuk Choi, Gerald Goh, Trent Walradt, et al.
Nature Medicine|May 7, 2021
Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trialXiaoxi Yao, David R Rushlow, Jonathan W Inselman, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Stroke|July 23, 2019
Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic StrokeGustavo Saposnik, Bijoy K Menon, Nima Kashani, et al.
The Journal of Allergy and Clinical Immunology. Global|January 8, 2026
Application of a natural language processing algorithm to early asthma ascertainment for adults in the era of electronic health recordsChung-Il Wi, Thanai Pongdee, Hee Yun Seol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2024
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaFrancine M Foss, Youn H Kim, H Miles Prince, et al.
Blood Advances|February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysisJoseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Blood|December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL ConsortiumMark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
British Journal of Haematology|April 20, 2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project NetworkMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Blood Advances|November 10, 2025
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative AnalysisJoseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Blood Advances|January 13, 2022
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomasMin Jung Koh, Mwanasha H Merrill, Min Ji Koh, et al.
Nature Genetics|July 21, 2015
Genomic landscape of cutaneous T cell lymphomaJaehyuk Choi, Gerald Goh, Trent Walradt, et al.
Nature Medicine|May 7, 2021
Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trialXiaoxi Yao, David R Rushlow, Jonathan W Inselman, et al.
Pageof 26